After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
March 17, 2022
After Alexion buyout, AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
aliu
Thu, 03/17/2022 – 08:53
Source link